Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Parshall v. CoLucid Pharmaceuticals, Inc. et al
Case Number:
1:17-cv-10197
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 15, 2017
Judge Steps Back From Lilly Investor Suit Over Ropes & Gray
A Massachusetts federal judge on Wednesday recused herself from a proposed class action by investors claiming they were cheated out of a better deal surrounding Eli Lilly & Co.'s $960 million acquisition of CoLucid Pharmaceuticals Inc., saying counsel Ropes & Gray LLP provides her with legal services.
-
February 06, 2017
Investors Sue Over Lilly's $960M Buy Of Migraine Drug Co.
About two weeks after Eli Lilly & Co. announced it was buying migraine treatment developer CoLucid Pharmaceuticals Inc. for $960 million, a CoLucid investor sued Friday in Massachusetts federal court, alleging the two blocked out competing offers and provided a proposed class of investors a subpar share of the deal.